[Hiring] Senior Medical Science Liaison @Scholar Rock

Role Description

The MSL/Sr MSL role will represent the real-time voice of KOL/HCP input related to product development opportunities and scientific exchange on pipeline and commercial products; conduct clinical presentations to payer organizations. The ideal candidate will be a strong leader with a proven ability to leverage their high scientific acumen to engage and educate on scientifically complex concepts and products. The preferred candidate will also have a proven strategic and innovative style combined with a flexible, hands-on nature that works with a high sense of urgency.

Position Responsibilities

• Become a SMA and apitegromab medical/clinical/scientific expert
• Build and foster relationships with local, regional, and national KOLs and possibly Payers
• Effectively deliver medical/clinical/scientific presentations to a diverse external audience
• Support clinical development activities, investigator recruitment, and education
• Development and execution of their Territory Management Plan (TMP) that is aligned with the overall Medical Goals and Plan
• Contribute to developing metrics, qualitative and quantitative MSL reports, SOPs/Business Practices for the MSL function
• Responding to unsolicited medical information requests submitted by SRRK field teams (e.g., Sales and Market Access)
• Compliantly partner with Sales and Market Access on high-level regional engagement
• Provide internal teams with insights from interactions and discussions with HCPs
• Co-create and deliver the MSL training
• Provide content development support for MSL materials, alongside the Director of Medical Communications
• Contribute to the development of the Global and US Medical Plans for apitegromab in SMA
• May be asked to participate in Advisory Board meetings, Advisory Group meetings, speaker trainings, etc.
• Coordinate local and regional investigator-initiated research (IIR)
• Compliantly manage IIR milestones and objectives
• Report on scientific sessions and conduct scientific exchange to unsolicited questions at SRRK medical booths at congresses
• May respond to and document unsolicited requests for scientific information
• Conduct all activities and responsibilities in accordance with all relevant legal, regulatory and corporate regulations and guidelines, including the Scholar Rock Business Conduct & Ethics, policies and procedures

Qualifications

• MD, PharmD, or PhD preferred. Advanced professional degree (NP, PT etc.) may be considered for candidates with significant clinical neuromuscular disease experience
• Minimum of 5 years of previous experience as an MSL in the biotechnology or pharmaceutical industry
• Neurology and/or rare disease experience with prior launch experience preferred
• Demonstrated knowledge of regulatory, commercial and clinical issues affecting the pharmaceutical industry is critical
• Excellent verbal and written communication, presentation, and interpersonal skills are essential
• Demonstrated strategic planning, organizational and project management abilities are required
• Ability to collaborate in a team environment and partner effectively across geographic areas and cross-functional groups is essential
• Experience in at least one “start-up” biopharma company is desirable
• Must be passionate about making a difference with the highest integrity; committed to ethics and scientific standards
• Demonstrated ability to work independently yet engage in collaborative decision making to complete tasks in a timely fashion, and function in a rapidly paced environment
• Experience with customer relationship management programs a plus
• This will be a remote position that will require extensive overnight travel (>50%)

Company Description

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.

Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients.